US Stock MarketDetailed Quotes

RXRX Recursion Pharmaceuticals

Watchlist

6.470
-0.120-1.82%

Close Mar 4 16:00 ET

6.680
+0.210+3.25%

Post 19:59 ET

2.60BMarket Cap-3.83P/E (TTM)

Recursion Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Recursion Pharmaceuticals Q4 2024 Earnings Date

Currency：USDFeb 28, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	19.04M	4.55M	-14.50M
Miss Est.	+74.85%	-58.26%	-76.13%
EPS	-0.46	-0.53	-0.07
Miss Est.	-8.76%	-26.19%	-16.05%

Analyst Rating

Buy

Feb 28, 2025

Recursion Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 22.740M	--
--	2025/Q1	-- / 20.540M	--
Feb 28, 2025	2024/Q4	4.546M / 19.043M	--
Nov 6, 2024	2024/Q3	26.082M / 29.829M	--
Aug 8, 2024	2024/Q2	14.417M / 13.286M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 22.740M--

--2025/Q1-- / 20.540M--

Feb 28, 20252024/Q44.546M / 19.043M--

Nov 6, 20242024/Q326.082M / 29.829M--

Aug 8, 20242024/Q214.417M / 13.286M--

Unlock Free Earnings Estimates

Open Account

Recursion Pharmaceuticals Earnings Reports

Recursion Pharmaceuticals | 10-K: FY2024 Annual Report

Feb 28 06:36 ET

Recursion Pharmaceuticals | 8-K: Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Feb 28 06:32 ET

Recursion Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 6, 2024 16:23 ET

Recursion Pharmaceuticals | 8-K: Recursion Provides Business Updates and Reports Third Quarter 2024 Financial Results

Nov 6, 2024 16:22 ET